LRP6, or low-density lipoprotein receptor-related protein 6, is an integral membrane protein that plays a pivotal role in the Wnt signaling pathway, a cascade vital for various cellular processes ranging from embryonic development to tissue homeostasis in adults. LRP6, along with its family member LRP5, acts as a co-receptor for Wnt ligands, forming a complex with the Frizzled family of receptors upon ligand binding. The activation of this complex initiates a cascade of intracellular events that ultimately lead to the stabilization of the protein β-catenin. Once stabilized, β-catenin translocates to the nucleus, where it interacts with transcription factors to modulate the expression of Wnt target genes. Given its central role in the Wnt signaling pathway, LRP6 is crucial in determining cellular fate, proliferation, and migration, among other functions.
Activators of LRP6 are molecules or compounds that enhance the activity or expression of LRP6. These activators can function by promoting the interaction of LRP6 with Wnt ligands, by bolstering its expression on the cell surface, or by stabilizing its conformation, ensuring its optimal function as a co-receptor. The presence of LRP6 activators can lead to potentiation of Wnt signaling, influencing the myriad of cellular processes governed by this pathway. A deeper understanding of LRP6 activators offers a window into the intricate dynamics of the Wnt signaling pathway and its implications on cellular decision-making processes. As research continues to unfold the mysteries of cell signaling, the role of LRP6 and its activators emerges as a key piece in the puzzle of cellular communication and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SKL2001 | 909089-13-0 | sc-507410 | 10 mg | $123.00 | ||
A direct agonist of the Wnt/β-catenin pathway. It acts by binding to the PDZ domain of the LRP6 protein, stabilizing the LRP6/β-catenin/Frizzled complex. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK3β, which can lead to the stabilization of β-catenin and activation of the Wnt signaling pathway. This might indirectly upregulate LRP6 expression. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
Inhibitor of GSK3β, thereby activating Wnt/β-catenin signaling, which can indirectly influence LRP6 expression or activity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK3β inhibitor that activates Wnt/β-catenin signaling. This can potentially influence LRP6 expression or activity indirectly. | ||||||